Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:10 AM
Study NCT ID:
NCT06199427
Status:
RECRUITING
Last Update Posted:
2024-01-10
First Post:
2023-12-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity
Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-28
First Submit QC Date:
None
Study First Post Date:
2024-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-28
Last Update Post Date:
2024-01-10
Last Update Post Date Type:
ACTUAL